Sign in
TMDX Stock Price, Chart, Stats & News
TransMedics Group, Inc.
Save
TransMedics Group, Inc. (TMDX) does not currently pay a dividend.
2.86B
Market cap
41.95x
Current P/E
37.31x
Forward P/E
TMDX chart
Fundamentals
Gross margin | 59.92% |
Operating margin | 17.93% |
Pretax margin | 17.76% |
Net margin | 31.43% |
Effective tax rate | -76.98% |
ROA | 17.81% |
ROE | 53.88% |
D/E | 0.99x |
Interest coverage ratio | 7.88x |
TMDX valuation
P/E | 41.95x |
P/S | 5.61x |
P/B | 7.16x |
P/CF | 17.58x |
P/FCF | 25.43x |
P/OCF | 17.58x |
PEG | 0.17x |
EV multiple | 23.01x |
About
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body.
Similar securities
Based on sector and market capitalization
Report issue